According to ROC analysis, the overall results demonstrated that BHLHE40 and DDIT4 expression in PBMCs represented potential diagnostic biomarkers in distinguishing HCC from the non-HCC group. This evidence concerns the gene BHLHE40 and hepatocellular carcinoma.